NRXP NRX Pharmaceuticals, Inc. stock chart & analysis
Conviction 40HealthcareScan · Thu, Oct 29, 2026NRX Pharmaceuticals, Inc. (NRXP) closed at $2.65 (-1.49%) on Oct 29, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 42, RS Rating 33, -47.6% from its 52-week high, -2.2% year to date. Sector: Healthcare · Pharmaceutical Preparations.
Price chart, 63 bars from Mon, Aug 3, 2026 to Thu, Oct 29, 2026. Last close $2.65, high $4.15, low $2.24.
Why NRXP moved
From the StockSetups movers recaps that covered NRXP, newest first. A recap states what was known that day.
- After hours+26.4%
NRX Pharmaceuticals jumped 26.4% after the bell, trading up to $3.35 versus the 4:00 PM ET regular-session close. About 1.69 million shares changed hands after hours, more than double the 20-day average of 765,239 for a full day. Market cap is only about $114.7M.
After-Hours Movers Oct 29, 2026: Why NRXP, WKHS, OSPN Jumped →
Financials as of Tue, Jun 30, 2026 · quarterly.
NRXP technical analysis
Trend
NRXP's moving averages are mixed — no clean uptrend or downtrend. It closed 14.1% below the 50-day ($3.08) and 10.7% below the 200-day ($2.97). ADX(14) at 35 points to a strong, established trend. It meets 3 of 8 trend-template criteria.
Momentum
RSI(14) is 42, in the bearish half of its range. MACD crossed above its signal line 2 sessions ago. A bullish RSI divergence is in place. A bullish MACD divergence is in place. Its RS Rating of 33 puts its weighted 12-month performance ahead of about 33% of the US market.
Volume and volatility
Volume on the latest session ran 1.4× its 20-day average. It trades about $2.0M a day on average. ATR(14) is $0.1678, 6.3% of price — its typical daily range. Chaikin Money Flow (-0.10) shows distribution.
Key levels
The chart pattern's support is $2.36 and its resistance $3.57. The 52-week range is $1.62 to $5.06; price is 47.6% below the high and 63.6% above the low. The VWAP anchored at the 52-week high is $3.54, above price.
Performance
NRXP returned +10.4% (1 week), -9.3% (1 month), -15.9% (3 months), -11.1% (6 months), -11.7% (1 year), -2.2% (year to date).
About NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
Pharmaceutical Preparations · Listed 2021 · 29 employees
Recent news
SEC filings
EDGAR filings in NRXP · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.